210 related articles for article (PubMed ID: 20693817)
21. Chronic prephthisical ocular hypotony treated by intravitreal triamcinolone acetonide.
Jonas JB; Vossmerbaeumer U; Kamppeter BA
Acta Ophthalmol Scand; 2004 Oct; 82(5):637. PubMed ID: 15453876
[No Abstract] [Full Text] [Related]
22. Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Bozkurt E; Kara N; Yazici AT; Yuksel K; Demirok A; Yilmaz OF; Demir S
Am J Ophthalmol; 2011 Dec; 152(6):976-981.e2. PubMed ID: 21861972
[TBL] [Abstract][Full Text] [Related]
23. Complications of intravitreal injection of triamcinolone acetonide.
Ozkiriş A; Erkiliç K
Can J Ophthalmol; 2005 Feb; 40(1):63-8. PubMed ID: 15825532
[TBL] [Abstract][Full Text] [Related]
24. Refractory ocular hypertension secondary to intravitreal injection of triamcinolone acetonide.
Detry-Morel M; Escarmelle A; Hermans I
Bull Soc Belge Ophtalmol; 2004; (292):45-51. PubMed ID: 15253490
[TBL] [Abstract][Full Text] [Related]
25. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M
Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
[TBL] [Abstract][Full Text] [Related]
26. Cataract surgery after intravitreal injection of triamcinolone acetonide.
Jonas JB; Kreissig I; Degenring RF
Eye (Lond); 2004 Apr; 18(4):361-4. PubMed ID: 15069430
[TBL] [Abstract][Full Text] [Related]
27. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.
Sutter FK; Simpson JM; Gillies MC
Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370
[TBL] [Abstract][Full Text] [Related]
28. The value of prednisolone acetate provocative test before intravitreal triamcinolone acetonide injections.
Saady AM; Fouad HM; Abdullatif AM; Helmy YAH; Macky TA; Mansour K
Eur J Ophthalmol; 2020 Jul; 30(4):730-737. PubMed ID: 30977377
[TBL] [Abstract][Full Text] [Related]
29. Refractory severe ocular hypertension after intravitreal triamcinolone acetonide injection.
Yang CS; Chen MJ; Chou CK; Hsu WM
Ophthalmologica; 2005; 219(6):413-5. PubMed ID: 16286805
[TBL] [Abstract][Full Text] [Related]
30. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
Shimura M; Nakazawa T; Yasuda K; Shiono T; Iida T; Sakamoto T; Nishida K
Am J Ophthalmol; 2008 May; 145(5):854-61. PubMed ID: 18328456
[TBL] [Abstract][Full Text] [Related]
31. Triamcinolone acetonide in ocular therapeutics.
Jermak CM; Dellacroce JT; Heffez J; Peyman GA
Surv Ophthalmol; 2007; 52(5):503-22. PubMed ID: 17719372
[TBL] [Abstract][Full Text] [Related]
32. Sterile endophthalmitis following intravitreal injection of triamcinolone acetonide.
Wang LC; Yang CM
Ocul Immunol Inflamm; 2005; 13(4):295-300. PubMed ID: 16159720
[TBL] [Abstract][Full Text] [Related]
33. Intravitreal triamcinolone for macular oedema: efficacy in relation to aetiology.
Sørensen TL; Haamann P; Villumsen J; Larsen M
Acta Ophthalmol Scand; 2005 Feb; 83(1):67-70. PubMed ID: 15715560
[TBL] [Abstract][Full Text] [Related]
34. Intravitreal triamcinolone acetonide compared with bevacizumab for the treatment of patients with macular edema secondary to central retinal vein occlusion.
Gokce G; Sobaci G; Durukan AH; Erdurman FC
Postgrad Med; 2013 Sep; 125(5):51-8. PubMed ID: 24113663
[TBL] [Abstract][Full Text] [Related]
35. Selective laser trabeculoplasty for intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Pizzimenti JJ; Nickerson MM; Pizzimenti CE; Kasten-Aker AG
Optom Vis Sci; 2006 Jul; 83(7):421-5. PubMed ID: 16840867
[TBL] [Abstract][Full Text] [Related]
36. Safety of intravitreal high-dose reinjections of triamcinolone acetonide.
Jonas JB; Degenring R; Kreissig I; Akkoyun I
Am J Ophthalmol; 2004 Dec; 138(6):1054-5. PubMed ID: 15629306
[TBL] [Abstract][Full Text] [Related]
37. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion.
Cheng KC; Wu WC; Chen KJ
Eye (Lond); 2009 Nov; 23(11):2023-33. PubMed ID: 19798117
[TBL] [Abstract][Full Text] [Related]
38. Outcome of intravitreal triamcinolone in uveitis.
Kok H; Lau C; Maycock N; McCluskey P; Lightman S
Ophthalmology; 2005 Nov; 112(11):1916.e1-7. PubMed ID: 16171868
[TBL] [Abstract][Full Text] [Related]
39. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
[TBL] [Abstract][Full Text] [Related]
40. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial.
Massin P; Audren F; Haouchine B; Erginay A; Bergmann JF; Benosman R; Caulin C; Gaudric A
Ophthalmology; 2004 Feb; 111(2):218-24; discussion 224-5. PubMed ID: 15019365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
